daniel petrylak, md, discusses the role of checkpoint inhibition therapy in urothelial carcinoma
Published 7 years ago • 14 plays • Length 3:03
Download video MP4
Download video MP3
Similar videos
-
1:11
daniel petrylak, md, on treating bladder cancer patients progressing on checkpoint inhibitors
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
0:25
daniel p. petrylak, md, on the role of dna repair gene mutations in metastatic urothelial carcinoma
-
15:57
checkpoint inhibitors
-
0:51
daniel p. petrylak, md, regarding pd-l1 biomarkers in the treatment of bladder cancer
-
19:16
checkpoint inhibitors for nmibc
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
14:42
managing toxicities associated with immune-checkpoint inhibitors
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
0:58
daniel p. petrylak, md, on immunotherapy & chemotherapy combinations in metastatic bladder cancer
-
0:39
daniel petrylak, md, offers recommendations for bladder cancer patients
-
0:39
daniel petrylak, md, on the current role of ctc tumor cell components via liquid biopsy pc treatment
-
6:18
checkpoint inhibitor therapy in prostate cancer
-
2:51
fda approves new bladder cancer drug | dr. daniel petrylak
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer
-
0:58
strategies for optimizing immune checkpoint inhibition in urothelial carcinoma
-
0:57
dr. petrylak on the keynote-045 trial for urothelial carcinoma
Clip.africa.com - Privacy-policy